Sector Perspective Therapeutics, Inc.

Aandelen

CATX

US46489V3024

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 22:00:00 20-11-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,7538 USD -3,85% Intraday-grafiek van Perspective Therapeutics, Inc. -20,07% -72,59%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-3,85%-20,07%-67,23%-76,52%-72,59%-64,44%-69,51%-84,62%-86,89% 91,03 mln.
-2,49%-3,76%-4,65%-16,14%+55,34%+50,31%+62,10%+8,06% - 63,66 mld.
-0,63%-2,91%+9,31%-3,66%+18,97%+6,20%+89,22%+235,88%+6.102,18% 58,56 mld.
-2,37%-2,22%+4,19%+11,16%+21,09%+22,87%+82,31%-14,09%+256,82% 54,19 mld.
-2,19%-6,15%+1,67%+5,90%+28,68%+11,92%+108,08%+7,24%+1.121,69% 44,66 mld.
-1,89%-7,28%-8,22%-4,00%+9,05%+13,22%+19,74%-8,33%+207,74% 40,51 mld.
-0,93%-0,47%+7,90%+9,74%+23,56%+19,73%+43,75%+16,18%+192,86% 36,27 mld.
+1,11%-6,44%-17,99%-23,87%+102,39%+130,68%+641,83%+441,85% - 34,89 mld.
-0,80%+0,61%+33,32%+62,03%+71,14%+77,26%+56,26%+26,88%+178,41% 32,26 mld.
-2,17%+16,65%+47,73%+12,99%-18,79%-29,21%+474,05%+363,99%+862,74% 31,01 mld.
-6,57%-12,37%-18,16%-17,49%+30,28%+27,20%-14,67%-62,97% - 21,45 mld.
-0,52%-5,42%-11,20%-26,99%-14,96%-16,51%-18,08%-72,06% - 20,07 mld.
-3,70%-6,64%-1,91%-0,34%+8,70%+4,16%+121,23%+168,95%+1.596,42% 17,08 mld.
-1,26%-8,23%+7,85%-0,82% - - - - - 16,58 mld.
-1,82%-6,33%+0,37%+20,38%+47,46%+54,69%+208,79%+258,46%+281,07% 15,77 mld.
-0,42%-3,05%+7,97%+17,14%+36,70%+48,66%+65,95%-22,61%+102,16% 16 mld.
-4,15%-7,00%-0,36%+7,85%+57,57%+93,93%+64,97%-17,26%+327,65% 15,06 mld.
-8,71%-20,29%-4,76%-20,00%+159,62%+156,62%+275,10%+684,99%+618,36% 13,83 mld.
-1,92%-4,08%+7,19%+7,14%+2,46%+18,08%-30,85%-34,76%+144,99% 13,99 mld.
-5,59%-11,07%-14,87%-25,25%+1,58%-9,37%+339,01% - - 12,15 mld.
Gemiddelde -2,54%-5,35%-1,09%-3,04%+29,91%+32,42%+132,59%+105,32%+850,44% 28 mld.
Gewogen gemiddelde per kap. -2,03%-3,52%+3,39%+1,21%+34,20%+34,00%+136,59%+102,44%+1.330,92%
  1. Beurs
  2. Aandelen
  3. Koers CATX
  4. Sector Perspective Therapeutics, Inc.